Intrinsic Value Partners, LLC Bristol Myers Squibb CO Transaction History

Intrinsic Value Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 17, 2023	SELL	$57.89 - $64.73 $72,304 - $80,847	-1,249 Reduced 26.26%	3,507 $203,000
Q2 2023 Aug 02, 2023	SELL	$63.71 - $70.74 $24,846 - $27,588	-390 Reduced 7.58%	4,756 $304,000
Q1 2023 Apr 18, 2023	SELL	$65.71 - $74.53 $2,628 - $2,981	-40 Reduced 0.77%	5,146 $356,000
Q4 2022 Jan 12, 2023	SELL	$68.48 - $81.09 $152,710 - $180,830	-2,230 Reduced 30.07%	5,186 $373,000
Q3 2022 Oct 13, 2022	SELL	$0.13 - $76.84 $354 - $209,773	-2,730 Reduced 26.91%	7,416 $527,000
Q2 2022 Jul 18, 2022	SELL	$72.62 - $79.98 $87,289 - $96,135	-1,202 Reduced 10.59%	10,146 $781,000
Q1 2022 Apr 28, 2022	SELL	$61.48 - $73.72 $14,263 - $17,103	-232 Reduced 2.0%	11,348 $829,000
Q4 2021 Feb 10, 2022	BUY	$53.63 - $62.52 $621,035 - $723,981	11,580 New	11,580 $722,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Intrinsic Value Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Intrinsic Value Partners, LLC with notifications on news.